PN
Patricia Nadworny
Chief Scientific Officer
FeynMed Solutions
I'm working on
3 months ago
developing our patented next generation poly-nanocrystalline silver platform technology. We are getting our advanced wound care product ready for regulatory submission, while validating and exploring applications for our antimicrobial/anti-inflammatory aqueous solutions.
I'm looking for
3 months ago
funding (grants or sponsored research, investments) and partnering opportunities, including co-development or licensing opportunities.
About
I completed my BSc in Chemical Engineering, followed by my PhD in Chemical Engineering & Biomedical Engineering. My research focuses on the development, validation, & commercialization of nanostructured materials, particularly silvers, for their anti-inflammatory & antimicrobial properties, focusing on wound care, lung (e.g., pneumonia, COPD, cystic fibrosis, ALI, ARDS, TENs, septic shock), ocular (e.g., various forms of conjunctivitis), & genitourinary (e.g., urinary tract infections, including catheter-associated infections, overactive bladder, painful bladder syndrome/interstitial cystitis, acute insults associated with the progression of radiation cystitis) applications. I am also interested in treatments for prevention of post-surgical abdominal adhesions and surgical site infections.
PN
Patricia Nadworny
Chief Scientific Officer
FeynMed Solutions
Work experience
Chief Scientific Officer
Chief Scientific Officer
2025 - 2025
Consultant
2019 - 2025
Top industry applications
Antimicrobial textilesChronic disease managementEmergency medical solutionsInfectious disease & antimicrobialsPharmaceuticals and drug deliveryRegenerative medicine
Expertise
AntimicrobialsBiofilmsBiotechnologyCoatingsInfectious DiseasesMicrobiology
Last updated Jul 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.